Guerbet SA (GBT) – Company Profile and SWOT Analysis

Guerbet SA (GBT) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Key Highlights

Guerbet SA (Guerbet) is a manufacturer of contrast agents. The company provides a wide range of imaging products, solutions, and services for Computed Tomography (CT)/Cath Lab examinations, magnetic resonance imaging (MRI), and interventional imaging. CT/Cath Lab contrast agents consist of iodinated active ingredients, and a few examinations of the digestive tract use barium-based products. MRI imaging uses gadolinium complexes. Guerbet has a presence in Europe, Asia, and North and South America. The company offers products directly through its sales structure, distributors, and license holders. Guerbet is headquartered in Villepinte, France.

Scope

• Detailed information on Guerbet SA required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Guerbet SA in the form of a SWOT analysis

• An in-depth view of the business model of Guerbet SA including a breakdown and examination of key business segments

• News about Guerbet SA, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Guerbet SA and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Guerbet SA as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Guerbet SAs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Boston Scientific Corp

SuperSonic Imagine SA

Nemoto Kyorindo Co Ltd

Merit Medical Systems Inc

ulrich GmbH & Co KG

GE HealthCare Technologies Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Guerbet SA - Key Facts

Guerbet SA - Key Employees

Guerbet SA - Key Employee Biographies

Guerbet SA - Major Products and Services

Guerbet SA - History

Guerbet SA - Company Statement

Guerbet SA - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Guerbet SA - Business Description

Product Category: Diagnostic Imaging

Overview

Performance

Product Category: Interventional Imaging

Overview

Performance

Geographical Segment: European Markets

Performance

Geographical Segment: Other Markets

Performance

R&D Overview

Guerbet SA - Corporate Strategy

Guerbet SA - SWOT Analysis

SWOT Analysis - Overview

Guerbet SA - Strengths

Guerbet SA - Weaknesses

Guerbet SA - Opportunities

Guerbet SA - Threats

Guerbet SA - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Guerbet SA, Medical Equipment, Deals By Year, 2020 to YTD 2026

Guerbet SA, Medical Equipment, Deals By Type, 2020 to YTD 2026

Guerbet SA, Recent Deals Summary

Section 5 – Company’s Recent Developments

Feb 05, 2026: Guerbet Releases 2025 revenue

Jan 28, 2026: Karim Boussebaa Appointed Chief Executive Officer of Guerbet

Jan 27, 2026: European Commission Approves New From-Birth Indication for Guerbet's Elucirem (Gadopiclenol)

Dec 17, 2025: Guerbet Appoints François Convenant Senior Vice President of Interventional Radiology and Executive Committee Member

Sep 24, 2025: Guerbet Reports H1 2025 Results with €387.8 Million Revenue

Sep 22, 2025: Guerbet : Change in General Management

Sep 15, 2025: Guerbet : Adjustment of 2025 Full-Year Financial Targets

Jul 24, 2025: Guerbet Reports H1 2025 Revenue

May 23, 2025: Changes in the Composition of the Guerbet Board of Directors

Apr 24, 2025: Guerbet : Q1 2025 Revenue

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Guerbet SA, Key Facts

Guerbet SA, Key Employees

Guerbet SA, Key Employee Biographies

Guerbet SA, Major Products and Services

Guerbet SA, History

Guerbet SA, Other Locations

Guerbet SA, Subsidiaries

Guerbet SA, Key Competitors

Guerbet SA, Ratios based on current share price

Guerbet SA, Annual Ratios

Guerbet SA, Annual Ratios (Cont…1)

Guerbet SA, Annual Ratios (Cont…2)

Guerbet SA, Interim Ratios

Guerbet SA, Medical Equipment, Deals By Year, 2020 to YTD 2026

Guerbet SA, Medical Equipment, Deals By Type, 2020 to YTD 2026

Guerbet SA, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Guerbet SA, Performance Chart (2020 – 2024)

Guerbet SA, Ratio Charts

Guerbet SA, Medical Equipment, Deals By Year, 2020 to YTD 2026

Guerbet SA, Medical Equipment, Deals by Type, 2020 to YTD 2026

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports